NFKB1 and systemic lupus erythematosus: Furthermore, EBNA2 can bind SLE risk loci in gene regulatory regions, such as NFkB subunits, resulting in a downstream alteration in gene expression and an increased risk of developing SLE and other inflammatory diseases, which further suggests a possible causal role of EBV for SLE [23].